{{Rsnum
|rsid=991804
|Chromosome=17
|position=34260706
|Orientation=minus
|GMAF=0.444
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 5.3 | 50.4 | 44.2
| HCB | 38.7 | 47.4 | 13.9
| JPT | 38.9 | 51.3 | 9.7
| YRI | 20.4 | 40.8 | 38.8
| ASW | 17.5 | 47.4 | 35.1
| CHB | 38.7 | 47.4 | 13.9
| CHD | 33.0 | 44.0 | 22.9
| GIH | 8.9 | 36.6 | 54.5
| LWK | 13.6 | 50.9 | 35.5
| MEX | 25.9 | 48.3 | 25.9
| MKK | 12.2 | 47.4 | 40.4
| TSI | 4.9 | 45.1 | 50.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22117412
|Title=[Association of polymorphic markers of CCL2 gene with essential hypertension]
}}

{{PMID Auto
|PMID=18587394
|Title=Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.
|OA=1
}}

{{PMID Auto
|PMID=18940815
|Title=MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana, West Africa.
|OA=1
}}

{{PMID Auto
|PMID=19068216
|Title=Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship.
|OA=1
}}

{{PMID Auto
|PMID=19408013
|Title=Strategies and issues in the detection of pathway enrichment in genome-wide association studies.
|OA=1
}}

{{PMID Auto
|PMID=20532202
|Title=Use of genome-wide expression data to mine the "Gray Zone" of GWA studies leads to novel candidate obesity genes.
|OA=1
}}

{{PMID Auto
|PMID=20570966
|Title=Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease.
|OA=1
}}

{{PMID Auto
|PMID=21304977
|Title=An investigation of genome-wide studies reported susceptibility loci for ulcerative colitis shows limited replication in north Indians.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}